1 unchanged sentence
Number Description
+Added: 2.1 Stock Purchase Agreement, dated February 26, 2026, by and among Tower Biosecurity, Inc., Ginkgo Bioworks, Inc., Ginkgo Biosecurity, LLC and, solely for the purposes of Section 11.09, Ginkgo Bioworks Holdings, Inc.
+Added: (incorporated by reference to Exhibit 1.1 of the Company’s Current Report on Form 8-K filed with the SEC on February 26, 2026).
3.1 Amended and Restated Certificate of Incorporation of Ginkgo Bioworks Holdings, Inc.
2 unchanged sentences
(incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed with the SEC on October 27, 2023).
−Removed: 10.1 Sales Agreement, dated September 4, 2025, by and among the Company and Allen & Company LLC (incorporated by reference to Exhibit 1.1 of the Company’s Current Report on Form 8-K filed with the SEC on September 4, 2025).
31.1* Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
15 unchanged sentences
Ginkgo Bioworks Holdings, Inc.
−Removed: November 6, 2025
/s/ Jason Kelly
Chief Executive Officer (Principal Executive Officer)
−Removed: November 6, 2025
/s/ Steven Coen
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.